QATAR UNIVERSITY
🇶🇦Qatar
Clinical Trials
10
Active:0
Completed:5
Trial Phases
1 Phases
Not Applicable:9
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (100.0%)An Online Physical Activity Coaching Intervention for People With PD in Qatar
Not Applicable
Not yet recruiting
- Conditions
- Parkinson Disease
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Qatar University
- Target Recruit Count
- 40
- Registration Number
- NCT06962930
- Locations
- 🇶🇦
Qatar University, Doha, Qatar
Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Irreversible Pulpitis
Not Applicable
Not yet recruiting
- Conditions
- Irreversible Pulpitis
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Qatar University
- Target Recruit Count
- 80
- Registration Number
- NCT06904781
Outcomes After Unified Versus Standard GDM Diagnosis
Not Applicable
Not yet recruiting
- Conditions
- Gestational DiabetesDiagnosisPregnancy
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Qatar University
- Target Recruit Count
- 2650
- Registration Number
- NCT06401629
Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis
Not Applicable
Recruiting
- Conditions
- Irreversible Pulpitis
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Qatar University
- Target Recruit Count
- 120
- Registration Number
- NCT06149845
- Locations
- 🇶🇦
Phcc - Airport Center, Doha, Qatar
🇶🇦PHCC- Leebaib Center, Doha, Qatar
Lactated Ringers vs Normal Saline in Patients With Acute Pancreatitis: A Bias-Adjusted Meta-analysis
Recruiting
- Conditions
- Acute Pancreatitis
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Qatar University
- Target Recruit Count
- 500
- Registration Number
- NCT05638555
- Locations
- 🇶🇦
Suhail Doi, Doha, Qatar
- Prev
- 1
- 2
- Next
News
Apabetalone Shows Promise as Epigenetic Therapy for Chronic Diseases
Qatar University researchers highlight Apabetalone's potential as an epigenetic therapy for treating various chronic diseases by targeting gene expression.